Peng, L., He, J., Zheng, Y., & Zeng, Q. (2025). Effects of monoclonal antibody daratumumab combined with ixazomib-based treatment regimen on survival of patients with relapsed/refractory multiple myeloma. Vojnosanitetski Pregled, 82(04). https://doi.org/10.2298/VSP231207016P